Insider · CIK 0001557832

Gallagher Cam

Reports to the SEC for 3 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001557832

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	IRDOpus Genetics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+784K sh	$1.15	+$902K	2,800,111
2026-09-08	IRDOpus Genetics, Inc. · Warrant (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−784K sh	—	—	0
2026-04-20	IRDOpus Genetics, Inc.A Award	Director	AAward	+24.4K sh	—	—	2,015,797
2026-01-06	IRDOpus Genetics, Inc.A Award	Director	AAward	+67K sh	—	—	1,991,430
2025-12-31	IRDOpus Genetics, Inc.A Award	Director	AAward	+33K sh	—	—	1,924,430
2025-12-29	IRDOpus Genetics, Inc.P Purchase	Director	PPurchase	+81K sh	$1.98	+$160K	1,891,430
2025-12-29	IRDOpus Genetics, Inc.P Purchase	Director	PPurchase	+83K sh	$1.97	+$163K	83,000
2025-08-25	IRDOpus Genetics, Inc.A Award	Director	AAward	+870K sh	$1.15	+$1M	1,810,430
2025-04-30	IRDOpus Genetics, Inc.A Award	Director	AAward	+79.5K sh	—	—	940,865
2025-04-30	IRDOpus Genetics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+79.6K sh	—	—	79,592
2025-03-24	IRDOpus Genetics, Inc.A Award	Director	AAward	+784K sh	—	—	861,361
2025-03-24	IRDOpus Genetics, Inc. · Warrants (right to buy)A Award	Director	AAward	+784K sh	—	—	784,314
2024-06-11	IRDOpus Genetics, Inc.A Award	Director	AAward	+41.1K sh	—	—	77,047
2024-06-11	IRDOpus Genetics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.2K sh	—	—	35,181
2024-05-31	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−9,597 sh	$11.98	−$115K	633,680
2024-02-12	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−1,173 sh	$11.44	−$13.4K	643,277
2024-02-02	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−11.6K sh	$11.54	−$133K	644,450
2024-02-01	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, President, Interim CFO	AAward	+193K sh	—	—	656,002
2024-02-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President, Interim CFO	AAward	+193K sh	—	—	192,500
2023-06-06	IRDOpus Genetics, Inc.A Award	Director	AAward	+11K sh	—	—	35,904
2023-06-06	IRDOpus Genetics, Inc. · Stock OptionA Award	Director	AAward	+9,639 sh	—	—	9,639
2023-05-31	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−9,242 sh	$26.40	−$244K	482,028
2023-05-31	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−18.5K sh	$26.21	−$486K	463,502
2023-02-14	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−8,501 sh	$19.96	−$170K	491,270
2023-02-13	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−3,332 sh	$20.42	−$68.1K	499,771
2023-02-06	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−9,428 sh	$22.22	−$210K	503,675
2023-02-06	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−572 sh	$23.04	−$13.2K	503,103
2023-02-01	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, President, Interim CFO	AAward	+161K sh	—	—	513,103
2023-02-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President, Interim CFO	AAward	+234K sh	—	—	233,908
2023-01-17	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−9,500 sh	$24.11	−$229K	352,511
2023-01-17	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−500 sh	$24.87	−$12.4K	352,011
2023-01-05	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−9,700 sh	$21.01	−$204K	362,311
2023-01-05	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−300 sh	$21.46	−$6,437.01	362,011
2023-01-04	IRDOpus Genetics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+1,574 sh	$0.00	+$0.157	24,928
2023-01-04	IRDOpus Genetics, Inc. · Series B Warrant (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−1,574 sh	—	—	0
2022-11-15	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−11.6K sh	$22.72	−$264K	372,911
2022-11-15	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−900 sh	$23.48	−$21.1K	372,011
2022-11-08	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−12.4K sh	$23.56	−$292K	384,511
2022-11-07	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−12.3K sh	$23.66	−$292K	397,042
2022-11-07	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−157 sh	$24.24	−$3,805.272	396,885
2022-10-17	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−12.5K sh	$23.51	−$294K	409,385
2022-10-06	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−10K sh	$22.62	−$226K	421,885
2022-10-05	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−7,004 sh	$21.92	−$154K	437,381
2022-10-05	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−5,496 sh	$22.83	−$125K	431,885
2022-09-16	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−8,866 sh	$24.38	−$216K	445,519
2022-09-16	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−1,134 sh	$24.99	−$28.3K	444,385
2022-09-15	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−8,426 sh	$25.10	−$212K	458,459
2022-09-15	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, President, Interim CFO	SSale	−4,074 sh	$25.59	−$104K	454,385
2022-06-13	IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-30	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, President, Interim CFO	AAward	+111K sh	—	—	466,885

Recent filings

Accepted (ET)
Sep 84
Gallagher Cam0001140361-26-035913
SEC(opens sec.gov)
Apr 224
Gallagher Cam0000905148-26-001785
SEC(opens sec.gov)
Jan 84
Gallagher Cam0000905148-26-000088
SEC(opens sec.gov)
Dec 314
Gallagher Cam0000905148-25-004511
SEC(opens sec.gov)
Aug 274
Gallagher Cam0000905148-25-003152
SEC(opens sec.gov)
May 24
Gallagher Cam0000905148-25-001427
SEC(opens sec.gov)
Mar 264
Gallagher Cam0000905148-25-001006
SEC(opens sec.gov)
Jun 134
Gallagher Cam0000905148-24-001711
SEC(opens sec.gov)
May 314
Gallagher Cam0001725160-24-000127
SEC(opens sec.gov)
Feb 124
Gallagher Cam0001725160-24-000041
SEC(opens sec.gov)
Feb 54
Gallagher Cam0001725160-24-000030
SEC(opens sec.gov)
Jun 84
Gallagher Cam0001140361-23-029020
SEC(opens sec.gov)

Companies

Address

C/O OPUS GENETICS, INC. 8 DAVIS DRIVE, SUITE 220

DURHAM, NC, 27713